Target intelligence / Profile preview

Histone H2A-like 3 (H2A.L.3)

Target
H2A.L.3
Molecular classification
Histone variant, Chromatin protein, Structural nucleosome component
01

Overview

Histone H2A-like 3 (H2A.L.3) is a member of the histone H2A variant family, which forms part of the octameric core of the nucleosome, the fundamental organizational unit of chromatin in eukaryotic cells[3][5]. Histone variants, including H2A.L.3, contribute to chromatin diversity by replacing canonical H2A in nucleosomes, thereby influencing nucleosome stability, higher-order chromatin structure, and chromatin function. Although core histones are highly conserved, H2A variants differ mostly in their C-terminal regions and may confer specific structural and functional properties to nucleosomes, such as altering DNA accessibility and interactions with other chromatin factors[3]. H2A variants are critical in developmental, tissue-specific, or stress-responsive chromatin states, but H2A.L.3 itself is not a validated therapeutic target, nor are there approved drugs or standard biomarker roles associated with it at present[3][4][5].

Other names
H2AL3H2A.L.3H2AL1RPH2A.L variant histone 3histone H2A-like 3H2A.L variant histone RH2A.L.3, pseudogeneH2AL3 (minor spelling/format variation)
02

Biological functions

Chromatin organizationRegulation of DNA accessibilityRegulation of transcriptionGenome packagingEpigenetic regulation
03

Disease associations

Other (Histone variants, including H2A types, have roles in cancer, development, and other chromatin-based diseases in general, but direct disease roles for H2A.L.3 are largely undocumented)

Beyond the preview

Go deeper on Histone H2A-like 3 (H2A.L.3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histone H2A-like 3 (H2A.L.3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call